Transmembrane signaling mechanisms of plexin
Transmembrane signaling mechanisms of plexin
批准号:
10549296
负责人:
Xuewu Zhang
金额:
$40.5万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-01-01 至 2024-01-31
关键词:
AddressBindingBiological AssayBiophysicsCardiovascular systemCell Surface ReceptorsCellsComplexCryoelectron MicroscopyCytoplasmCytoplasmic TailDevelopmentDiseaseDistalFoundationsGoalsIn VitroInjuryLengthLigandsLipid BilayersLipidsMediatingMembraneN-terminalNerve RegenerationNeuropilinsPathway interactionsPlayProcessProteinsRegulationResearchRoleSemaphorinsSignal PathwaySignal TransductionSignaling ProteinStructureSystemTransmembrane DomainVisualizationX-Ray Crystallographydesigndimergenetic regulatory proteinimprovedmalignant neurologic neoplasmsnervous system developmentnervous system disorderneuron regenerationnovel strategiesnovel therapeuticsplexinreceptorreceptor bindingreconstitutiontargeted treatment
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Plexins are single-pass transmembrane receptors that serve as the primary receptors for the guidance
molecules semaphorins. Some semaphorins also require the neuropilin co-receptor for binding and activating
plexin. Semaphorin/plexin/neuropilin-mediated signaling is essential for many processes, including the
development of the nervous system and the cardiovascular system. Malfunction of this signal pathway is
associated with diseases such as neurological disorder and cancer. A better understanding of the mechanisms
of this pathway will provide a foundation for developing targeted therapies for these diseases and improving
neuronal regeneration after injury. Plexin and neuropilin are both large proteins, and use their N-terminal
membrane distal domains to bind semaphorin. Semaphorin are dimeric molecules, and activate plexin by
inducing the formation of the active dimer. One major remaining mechanistic question is how the membrane
proximal and transmembrane regions in plexin and neuropilin couple the semaphorin binding at the N-terminal
domains to the activation of the plexin cytoplasmic domain, which relays the signal to downstream pathways.
There is evidence suggesting that the membrane proximal and transmembrane regions play active roles in
plexin activation. Another outstanding question concerns how many of the newly identified binding partners of
plexin contribute to the signaling. The proposed research will be focused on addressing these mechanistic
questions. In Aim 1, we will analyze how the interactions mediated by the transmembrane region of plexin
regulate the formation of the plexin active dimer. We will design plexin constructs that contain the
transmembrane region and cytoplasmic region but not the N-terminal autoinhibitory domains. These constructs
are expected to form the active dimer spontaneously in the absence of semaphorin binding. We will determine
the structure of this active dimer through either X-ray crystallography or cryo-electron microscopy to visualize
how the transmembrane region interacts and promotes the formation of the plexin active dimer. In Aim 2, we
will pursue the structure of full-length plexin and neuropilin in complex with semaphorin by using cryo-electron
microscopy. These structures will provide a direct view of the entire receptor/ligand complex, and reveal how
the membrane proximal and transmembrane regions couple the binding of semaphorin at the N-terminal
domains to the cytoplasmic domains. In Aim 3, we will investigate the interactions and regulation of plexin by
regulatory proteins. Some of these proteins may only exert their regulatory function in the context of the lipid
bilayer, which we will investigate by using plexin reconstituted in lipid discs. The structural studies will be
correlated by in vitro biophysical and cell-based functional assays. In addition, new approaches developed for
the plexin system will be used to study other transmembrane signaling proteins in order to gain a general
understanding of the principles of transmembrane signaling.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Transmembrane signaling mechanisms of plexin - Supplement
-
批准号:10386725
-
项目类别:
-
资助金额:$6.45万
-
财政年份:2019
-
负责人:Xuewu Zhang
-
依托单位:
Transmembrane signaling mechanisms of plexin
-
批准号:10311997
-
项目类别:
-
资助金额:$40.5万
-
财政年份:2019
-
负责人:Xuewu Zhang
-
依托单位:
Structural and functional analyses of the FAM46 proteins.
-
批准号:10334419
-
项目类别:
-
资助金额:$36.32万
-
财政年份:2018
-
负责人:Xuewu Zhang
-
依托单位:
Structural and functional analyses of the FAM46 proteins.
-
批准号:10087901
-
项目类别:
-
资助金额:$37.06万
-
财政年份:2018
-
负责人:Xuewu Zhang
-
依托单位:
Signaling and Regulation Mechanisms of Plexin
-
批准号:8762128
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2009
-
负责人:Xuewu Zhang
-
依托单位:
Regulation Mechanisms for the GTPase activating protein domain of plexins
-
批准号:8515457
-
项目类别:
-
资助金额:$29.7万
-
财政年份:2009
-
负责人:Xuewu Zhang
-
依托单位:
Signaling and Regulation Mechanisms of Plexin
-
批准号:9314577
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2009
-
负责人:Xuewu Zhang
-
依托单位:
Regulation Mechanisms for the GTPase activating protein domain of plexins
-
批准号:7937784
-
项目类别:
-
资助金额:$31.09万
-
财政年份:2009
-
负责人:Xuewu Zhang
-
依托单位:
Regulation Mechanisms for the GTPase activating protein domain of plexins
-
批准号:8310038
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2009
-
负责人:Xuewu Zhang
-
依托单位:
Signaling and Regulation Mechanisms of Plexin
-
批准号:8894017
-
项目类别:
-
资助金额:$32.12万
-
财政年份:2009
-
负责人:Xuewu Zhang
-
依托单位:
Regulation Mechanisms for the GTPase activating protein domain of plexins
-
批准号:8115845
-
项目类别:
-
资助金额:$30.78万
-
财政年份:2009
-
负责人:Xuewu Zhang
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: